These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23569530)

  • 41. Supraclavicular lymph node as the first presentation and late skin metastasis: an unusual clinical course for prostate cancer.
    Çulpan M; Yıldırım A; Turan T; Çaşkurlu T
    Turk J Urol; 2018 Jan; 44(1):75-78. PubMed ID: 29484232
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transforming growth factor-beta 1: comparative immunohistochemical localization in human primary and metastatic prostate cancer.
    Eastham JA; Truong LD; Rogers E; Kattan M; Flanders KC; Scardino PT; Thompson TC
    Lab Invest; 1995 Nov; 73(5):628-35. PubMed ID: 7474936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Recrudescent prostate cancer with a low serum PSA level and a high serum CEA level treated with docetaxel : a case report].
    Fujita M; Goto T; Uchida K; Saiki S; Arima R
    Hinyokika Kiyo; 2013 Mar; 59(3):183-8. PubMed ID: 23633635
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A case report of distant lymph nodes metastases from prostate cancer imaged with 201Tl and 99mTc-MIBI].
    Ikekubo K; Hino M; Ito H; Ohtsuka H; Saiki Y
    Kaku Igaku; 2003 Nov; 40(4):439-43. PubMed ID: 14733108
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostate cancer with supraclavicular lymphadenopathy and bulky abdominal tumor.
    Kosugi S; Mizumachi S; Kitajima A; Igarashi T; Hamada T; Kaya H; Kurihara K; Ogasawara K; Sakata H; Yamamoto M; Nagamine M; Yamazaki H
    Intern Med; 2007; 46(14):1135-8. PubMed ID: 17634715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HOXB13 protein expression in metastatic lesions is a promising marker for prostate origin.
    Varinot J; Furudoï A; Drouin S; Phe V; Penna RR; Roupret M; Bitker MO; Cussenot O; Compérat E
    Virchows Arch; 2016 May; 468(5):619-22. PubMed ID: 26931741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG
    Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sonographic assessment of cervical lymphadenopathy: role of high-resolution and color Doppler imaging.
    Gupta A; Rahman K; Shahid M; Kumar A; Qaseem SM; Hassan SA; Siddiqui FA
    Head Neck; 2011 Mar; 33(3):297-302. PubMed ID: 20652889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unusual presentation of prostate cancer with generalized lymphadenopathy and unilateral leg edema.
    Turkbey B; Basaran C; Boge M; Karcaaltincaba M; Akata D
    JBR-BTR; 2008; 91(5):211-3. PubMed ID: 19051944
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A case of completely responding stage D2 prostatic cancer with no evidence of disease 14 years after diagnosis].
    Tsuzuki M; Kawakami S; Yonese J; Ueda T; Kageyama S; Yamauchi T; Kawai T
    Hinyokika Kiyo; 1994 Sep; 40(9):837-40. PubMed ID: 7801848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Supraclavicular metastasis from prostate cancer: unusual case and literature review.
    Ascio NM; Qureshi A; Banayan E; Asarian A; Genato R; Xiao P
    J Surg Case Rep; 2023 Mar; 2023(3):rjad091. PubMed ID: 36896153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prostatic carcinoma presenting as neck lymph node metastases: report of two cases].
    Uemura M; Hirai T; Kanno N; Nishimura K; Mizutani S; Miyoshi S; Yoshida K; Kawano K
    Hinyokika Kiyo; 2001 Oct; 47(10):755-8. PubMed ID: 11758362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Generalized lymphadenopathy: a rare presentation of disseminated prostate cancer.
    Oyan B; Engin H; Yalcin S
    Med Oncol; 2002; 19(3):177-9. PubMed ID: 12482129
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significance of micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction in patients with clinically localized prostate cancer undergoing radical prostatectomy after neoadjuvant hormonal therapy.
    Miyake H; Kurahashi T; Hara I; Takenaka A; Fujisawa M
    BJU Int; 2007 Feb; 99(2):315-20. PubMed ID: 17155986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial.
    Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
    Lancet Oncol; 2014 Sep; 15(10):1076-89. PubMed ID: 25130995
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Macrophage type 2 differentiation in a patient with laryngeal squamous cell carcinoma and metastatic prostate adenocarcinoma to the cervical lymph nodes.
    Topf MC; Tuluc M; Harshyne LA; Luginbuhl A
    J Immunother Cancer; 2017 Jul; 5(1):60. PubMed ID: 28716144
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An Improbable Case of Ascites.
    Visconti V; Fernandes A; Oliveira I
    Eur J Case Rep Intern Med; 2020; 7(12):001474. PubMed ID: 33585325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.